We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Microchip Rises 17% YTD: Should You Buy, Sell or Hold the Stock?
Read MoreHide Full Article
Key Takeaways
Microchip expects data-center revenues to rise about 69% to roughly $1 billion in 2026.
MCHP sees industrial and automotive demand recovering as customers largely normalize inventories.
MCHP faces supply constraints, $5.36 billion in long-term debt and a relatively premium valuation.
Microchip (MCHP - Free Report) shares have risen 17.3% year to date (YTD), underperforming the Zacks Computer and Technology sector’s appreciation of 19.8%. The rally can be attributed to strengthening demand, normalization of customer inventories and growing exposure to data-center, aerospace and defense markets.
However, Microchip’s prospects remain challenging due to supply chain constraints, rising costs and stiff competition from the likes of Texas Instruments (TXN - Free Report) , Analog Devices (ADI - Free Report) and onsemi (ON - Free Report) . YTD, shares of Texas Instruments, Analog Devices and onsemi have returned 56.1%, 41.2% and 32.4%, respectively. So, what should investors do with the MCHP stock? Let’s dig deep to find out.
MCHP Stock’s Price Performance
Image Source: Zacks Investment Research
MCHP Shares Are Trading at a Premium
Microchip shares are trading at a premium, as suggested by a Value Score of D.
In terms of price/free cash flow, the company is trading at 37.06X, a premium compared with the broader sector’s 36.78X and onsemi’s 18.90X, respectively. However, MCHP is trading at a discount compared with Texas Instruments and Analog Devices’ P/E multiples of 46.21 and 37.92X, respectively.
MCHP Stock’s Valuation
Image Source: Zacks Investment Research
MCHP’s Prospects Ride on Data Center Tailwinds
Microchip’s expanding data-center exposure is expected to be a major growth driver. The company expects total data-center revenues to rise roughly 69% from about $591 million in calendar 2025 to approximately $1 billion in 2026. The opportunity extends beyond PCIe switches and retimers to power management, microcontrollers, FPGAs, timing, security, mixed-signal and memory products.
The PCIe Gen6 portfolio is a key catalyst. Microchip had 14 Gen6 design wins as of September, comprising 12 PCIe switch wins and two retimer wins. These programs are expected to begin generating meaningful revenues in calendar 2027, with one disclosed opportunity potentially representing around $100 million in annual revenues. The company estimates the longer-term PCIe and retimer addressable markets at roughly $10 billion and $2 billion, respectively.
Moreover, recovery in industrial and automotive demand is noteworthy. Industrial revenues rose 24.3% year over year in the first quarter of fiscal 2027, while automotive revenues increased 29.3% year over year. Microchip stated that customers in these markets have largely corrected inventories and are placing higher order levels, which bodes well for future growth.
Aerospace and defense is emerging as another structural growth opportunity for the company. Revenues from this market increased 45.6% year over year in the first quarter of fiscal 2027 and represented 16.7% of sales. Microchip benefits from a broad portfolio of high-reliability and radiation-tolerant products built partly through the Microsemi acquisition. The company believes the current aerospace and defense buildup remains relatively early, supporting the potential for a multi-year demand cycle.
Microchip has encountered constraints in certain foundry process nodes, substrates, subcontracting and test capacity, causing lead times to extend across parts of the portfolio. The company has noted that AI-related industry demand is tightening some external foundry and assembly-and-test capacity. Approximately 65% of Microchip’s wafer fabrication is externally sourced. If demand continues to accelerate faster than supplier capacity, Microchip could struggle to fully satisfy customer orders despite having substantial internal manufacturing capacity.
Meanwhile, the company had $5.36 billion of long-term debt as of June 30, 2026. Continued debt reduction will consume a portion of cash generation and could limit flexibility for larger buybacks, acquisitions or other capital deployment until leverage falls further.
Microchip remains exposed to cyclical industrial, automotive and consumer semiconductor markets. The company’s Gen6 opportunity is attractive, but MCHP is rebuilding its competitive position after missing much of the PCIe Gen5 cycle because its products reached the market roughly 18-24 months late. The company acknowledges that Microchip remains a relatively small player in Gen6 currently.
The Zacks Consensus Estimate for fiscal 2027 earnings is pegged at $3.63 per share, unchanged over the past 30 days and indicates 121.34% growth over fiscal 2026’s reported figure. The consensus mark for fiscal 2027 revenues is pegged at $6.41 billion, suggesting 35.91% growth from fiscal 2026’s reported figure.
Microchip Technology Incorporated Price and Consensus
Microchip expects second-quarter fiscal 2027 net sales between $1.59 billion and $1.618 billion. The company expects non-GAAP earnings of 91-95 cents per share.
The Zacks Consensus Estimate for second-quarter fiscal 2027 earnings is pegged at 92 cents per share, up a couple of cents over the past 30 days and indicating 162.86% growth over the year-ago quarter’s reported figure. The consensus mark for fiscal second-quarter revenues is pegged at $1.6 billion, suggesting 40.55% growth from the year-ago quarter’s reported figure.
Conclusion
Microchip’s improving demand environment, normalization of customer inventories and growing exposure to data center, aerospace and defense markets support its growth prospects. The anticipated recovery in industrial and automotive markets, alongside the expanding PCIe Gen6 opportunity, should further aid revenues. However, supply constraints, elevated debt, cyclical end-market exposure and intense competition remain key concerns. Moreover, the stock’s relatively premium valuation leaves limited room for execution missteps. With near-term growth prospects balanced by these risks, investors may prefer to maintain a cautious stance on MCHP shares at present.
View the Zacks #1 Rank List
Image: Bigstock
Microchip Rises 17% YTD: Should You Buy, Sell or Hold the Stock?
Key Takeaways
Microchip (MCHP - Free Report) shares have risen 17.3% year to date (YTD), underperforming the Zacks Computer and Technology sector’s appreciation of 19.8%. The rally can be attributed to strengthening demand, normalization of customer inventories and growing exposure to data-center, aerospace and defense markets.
However, Microchip’s prospects remain challenging due to supply chain constraints, rising costs and stiff competition from the likes of Texas Instruments (TXN - Free Report) , Analog Devices (ADI - Free Report) and onsemi (ON - Free Report) . YTD, shares of Texas Instruments, Analog Devices and onsemi have returned 56.1%, 41.2% and 32.4%, respectively. So, what should investors do with the MCHP stock? Let’s dig deep to find out.
MCHP Stock’s Price Performance
Image Source: Zacks Investment Research
MCHP Shares Are Trading at a Premium
Microchip shares are trading at a premium, as suggested by a Value Score of D.
In terms of price/free cash flow, the company is trading at 37.06X, a premium compared with the broader sector’s 36.78X and onsemi’s 18.90X, respectively. However, MCHP is trading at a discount compared with Texas Instruments and Analog Devices’ P/E multiples of 46.21 and 37.92X, respectively.
MCHP Stock’s Valuation
Image Source: Zacks Investment Research
MCHP’s Prospects Ride on Data Center Tailwinds
Microchip’s expanding data-center exposure is expected to be a major growth driver. The company expects total data-center revenues to rise roughly 69% from about $591 million in calendar 2025 to approximately $1 billion in 2026. The opportunity extends beyond PCIe switches and retimers to power management, microcontrollers, FPGAs, timing, security, mixed-signal and memory products.
The PCIe Gen6 portfolio is a key catalyst. Microchip had 14 Gen6 design wins as of September, comprising 12 PCIe switch wins and two retimer wins. These programs are expected to begin generating meaningful revenues in calendar 2027, with one disclosed opportunity potentially representing around $100 million in annual revenues. The company estimates the longer-term PCIe and retimer addressable markets at roughly $10 billion and $2 billion, respectively.
Moreover, recovery in industrial and automotive demand is noteworthy. Industrial revenues rose 24.3% year over year in the first quarter of fiscal 2027, while automotive revenues increased 29.3% year over year. Microchip stated that customers in these markets have largely corrected inventories and are placing higher order levels, which bodes well for future growth.
Aerospace and defense is emerging as another structural growth opportunity for the company. Revenues from this market increased 45.6% year over year in the first quarter of fiscal 2027 and represented 16.7% of sales. Microchip benefits from a broad portfolio of high-reliability and radiation-tolerant products built partly through the Microsemi acquisition. The company believes the current aerospace and defense buildup remains relatively early, supporting the potential for a multi-year demand cycle.
Supply Constraints, Elevated Debt Level Risks Hurt MCHP
Microchip has encountered constraints in certain foundry process nodes, substrates, subcontracting and test capacity, causing lead times to extend across parts of the portfolio. The company has noted that AI-related industry demand is tightening some external foundry and assembly-and-test capacity. Approximately 65% of Microchip’s wafer fabrication is externally sourced. If demand continues to accelerate faster than supplier capacity, Microchip could struggle to fully satisfy customer orders despite having substantial internal manufacturing capacity.
Meanwhile, the company had $5.36 billion of long-term debt as of June 30, 2026. Continued debt reduction will consume a portion of cash generation and could limit flexibility for larger buybacks, acquisitions or other capital deployment until leverage falls further.
Microchip remains exposed to cyclical industrial, automotive and consumer semiconductor markets. The company’s Gen6 opportunity is attractive, but MCHP is rebuilding its competitive position after missing much of the PCIe Gen5 cycle because its products reached the market roughly 18-24 months late. The company acknowledges that Microchip remains a relatively small player in Gen6 currently.
MCHP’s FY27 Earnings Estimate Revision Shows Steady Trend
The Zacks Consensus Estimate for fiscal 2027 earnings is pegged at $3.63 per share, unchanged over the past 30 days and indicates 121.34% growth over fiscal 2026’s reported figure. The consensus mark for fiscal 2027 revenues is pegged at $6.41 billion, suggesting 35.91% growth from fiscal 2026’s reported figure.
Microchip Technology Incorporated Price and Consensus
Microchip Technology Incorporated price-consensus-chart | Microchip Technology Incorporated Quote
Microchip expects second-quarter fiscal 2027 net sales between $1.59 billion and $1.618 billion. The company expects non-GAAP earnings of 91-95 cents per share.
The Zacks Consensus Estimate for second-quarter fiscal 2027 earnings is pegged at 92 cents per share, up a couple of cents over the past 30 days and indicating 162.86% growth over the year-ago quarter’s reported figure. The consensus mark for fiscal second-quarter revenues is pegged at $1.6 billion, suggesting 40.55% growth from the year-ago quarter’s reported figure.
Conclusion
Microchip’s improving demand environment, normalization of customer inventories and growing exposure to data center, aerospace and defense markets support its growth prospects. The anticipated recovery in industrial and automotive markets, alongside the expanding PCIe Gen6 opportunity, should further aid revenues. However, supply constraints, elevated debt, cyclical end-market exposure and intense competition remain key concerns. Moreover, the stock’s relatively premium valuation leaves limited room for execution missteps. With near-term growth prospects balanced by these risks, investors may prefer to maintain a cautious stance on MCHP shares at present.
Microchip currently has a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.